(19)
(11) EP 1 487 796 A1

(12)

(43) Date of publication:
22.12.2004 Bulletin 2004/52

(21) Application number: 03745585.4

(22) Date of filing: 25.03.2003
(51) International Patent Classification (IPC)7: C07D 215/00, C07D 233/02, C07D 235/02, C07D 317/44, C07D 405/00, C07D 409/00, A61K 31/38, A61K 31/40, A61K 31/415
(86) International application number:
PCT/US2003/009045
(87) International publication number:
WO 2003/082826 (09.10.2003 Gazette 2003/41)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 28.03.2002 US 368462 P
04.12.2002 US 372150 P

(71) Applicant: NEUROGEN CORPORATION
Branford, CT 06405 (US)

(72) Inventors:
  • GAO, Yang
    Branford, CT 06405 (US)
  • HUTCHISON, Alan
    Madison, CT 06443 (US)
  • PETERSON, John
    Durham, CT 06422 (US)
  • PRINGLE, Wallace
    Guilford, CT 06437 (US)
  • THURKAUF, Andrew
    Ridgefield, CT 06877 (US)
  • YOON, Taeyoung
    Guilford, CT 06437 (US)
  • ZHAO, He
    Branford, CT 06405 (US)

(74) Representative: Adam, Holger, Dr. et al
Kraus & Weisert,Patent- und Rechtsanwälte,Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) SUBSTITUTED BIARYL AMIDES AS C5A RECEPTOR MODULATORS